BASILE, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 193
EU - Europa 112
AS - Asia 58
Continente sconosciuto - Info sul continente non disponibili 1
Totale 364
Nazione #
US - Stati Uniti d'America 193
SE - Svezia 49
IT - Italia 27
CN - Cina 25
SG - Singapore 20
RU - Federazione Russa 17
IN - India 10
DE - Germania 8
IE - Irlanda 5
FI - Finlandia 3
HK - Hong Kong 3
BE - Belgio 1
EU - Europa 1
GB - Regno Unito 1
GR - Grecia 1
Totale 364
Città #
New York 35
Ashburn 27
Boardman 21
Shanghai 17
Singapore 13
Lawrence 11
Princeton 11
Milan 10
Pune 8
Moscow 6
Dublin 5
Rome 5
Hanover 3
Seattle 3
Turin 3
Washington 3
Cancello e Arnone 2
Detroit 2
Helsinki 2
Hong Kong 2
Hyderabad 2
Silver Spring 2
Athens 1
Borås 1
Brussels 1
Ferrara 1
Florence 1
Gaithersburg 1
Lappeenranta 1
Los Angeles 1
Manchester 1
Mountain View 1
Pisa 1
Redwood City 1
San Antonio 1
Santa Clara 1
Temecula 1
Vaprio d'Adda 1
Totale 209
Nome #
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 26
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 26
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 25
Bladder-sparing combination treatments for muscle-invasive bladder cancer: A plea for standardized assessment and definition of clinical trials endpoints 23
A global approach to improving penile cancer care 22
Assessing in-hospital morbidity after urethroplasty using the European Association of Urology Quality Criteria for standardized reporting 20
Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma 19
Intermediate- and high-risk nonmuscle invasive bladder cancer: Where do we stand? 19
The impact of intraoperative bleeding on the risk of chronic kidney disease after nephron-sparing surgery 18
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 17
Is There a Detrimental Effect of Antibiotic Therapy in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Pembrolizumab? 17
The Learning Curve for Radical Nephrectomy for Kidney Cancer: Implications for Surgical Training 16
Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer 16
"Case of the month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses" 16
Cytoreductive Nephrectomy in Metastatic Patients with Signs or Symptoms: Implications for Renal Cell Carcinoma Guidelines 16
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time 15
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 15
Advanced Squamous Cell Carcinomas of the Pelvic and Perineal Region: A Comprehensive Genomic Profiling Study 13
Re: Siamak Daneshmand, Azadeh Nazemi. Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence. Eur Urol Focus 2020;6:639–41 13
Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy 11
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 10
Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial 10
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 9
The Role of 99mTc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis 8
null 1
Totale 401
Categoria #
all - tutte 4.308
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.308


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 3 1 0 0 0 0 0
2021/202224 0 5 0 6 2 0 1 0 1 0 0 9
2022/2023100 27 18 3 7 4 12 8 11 2 0 4 4
2023/2024241 12 20 22 19 15 47 1 40 5 9 14 37
2024/202532 32 0 0 0 0 0 0 0 0 0 0 0
Totale 401